← Eichor
Condition: Non Small Cell Lung Cancer Stage Iiib Iv Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Non Small Cell Lung Cancer Stage Iiib Iv

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Phase 3 · 604 location(s) · National Cancer Institute (NCI) · NCT04181060A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-L
Phase 3 · 403 location(s) · Amgen · NCT05920356Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Phase 2 · 345 location(s) · National Cancer Institute (NCI) · NCT03191149Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Os
Phase 2 · 16 location(s) · Goethe University · NCT05281406Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatmen
Phase 2 · 13 location(s) · City of Hope Medical Center · NCT07288034Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.
Phase N/A · 1 location(s) · Gene Solutions · NCT06167460AK129 Combination Therapy for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Akeso · NCT06943820Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The
Phase 3 · 322 location(s) · National Cancer Institute (NCI) · NCT06096844EMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC Patients
Phase N/A · 4 location(s) · Hedera Dx SA · NCT07096258Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined with
Phase 2 · 1 location(s) · Zibo Municipal Hospital · NCT07198217Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients
Phase 1/Phase 2 · 1 location(s) · Precision Biotech Taiwan Corp. · NCT04616209Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT05269381Tislelizumab Combined With sCRT in Stage IIIB/C-IV Non-Squamous Non-Small Cell Lung Cancer：A Prospective, Single-Arm, Ph
Phase 2 · 1 location(s) · Zibo Municipal Hospital · NCT07085182Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cel
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT03948100A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cel
Phase 2 · 12 location(s) · Regeneron Pharmaceuticals · NCT07154290Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03819296
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.